Exercise-induced Desaturation During a Six-minute Walk Test is Associated with Poor Clinical Outcomes in Patients with Pulmonary Arterial Hypertension

Overview

Journal Clin Hypertens

Publisher Biomed Central

Date 2023 Dec 1

PMID 38037152

Authors

Jung Hyun Choi

Myung-Jun Shin

Byeong-Ju Lee

Jae-Hyeong Park

Affiliations

Soon will be listed here.

Abstract

Background: The six-minute walk test (6MWT) is an established exercise test for patients with pulmonary arterial hypertension (PAH), affording insight into both exercise intolerance and overall prognosis. Despite the widespread application of the 6MWT, the prognostic implications of exercise-induced desaturation (EID) during this test has been inadequately studied in PAH patients. Thus, we evaluated the occurrence of EID and its prognostic significance in PAH patients.

Methods: We analyzed PAH patients in a single-center cohort from April 2016 to March 2021. EID was defined as a reduction in oxygen saturation exceeding 4% from the baseline or to below 90% at any point during the test.

Results: We analyzed 20 PAH patients in this cohort, primarily consisting of 16 females with an average age of 48.4 ± 13.3 years. Among them, ten exhibited EID. Baseline characteristics, echocardiographic data and right heart catheterization data were similar between the two groups. However, total distance (354.3 ± 124.4 m vs. 485.4 ± 41.4 m, P = 0.019) and peak oxygen uptake (12.9 ± 3.2 mL/kg⋅min vs. 16.4 ± 3.6 mL/kg⋅min, P = 0.019) were significantly lower in the EID group. During the total follow-up duration of 51.9 ± 25.7 months, 17 patients had at least one adverse clinical event (2 deaths, 1 lung transplantation, and 13 hospital admissions). The presence of EID was associated with poor clinical outcome (hazard ratio = 6.099, 95% confidence interval = 1.783-20.869, P = 0.004).

Conclusions: During the 6MWT, EID was observed in a half of PAH patients and emerged as a significant prognostic marker for adverse clinical events.

Citing Articles

Pediatric Pulmonary Arterial Hypertension; is it Possible to Predict its Outcome?.

Agha H, Hegazy R, Gamal A, Essam R, Elmessih A, Behairy A J Saudi Heart Assoc. 2025; 36(4):408-419.

PMID: 39763633 PMC: 11702901. DOI: 10.37616/2212-5043.1398.

References

Duffield R, Dawson B, Pinnington H, Wong P . Accuracy and reliability of a Cosmed K4b2 portable gas analysis system. J Sci Med Sport. 2004; 7(1):11-22. DOI: 10.1016/s1440-2440(04)80039-2. View

Hoeper M, Pausch C, Olsson K, Huscher D, Pittrow D, Grunig E . COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2021; 60(1). PMC: 9260123. DOI: 10.1183/13993003.02311-2021. View

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View

Panos R, Eschenbacher W . Exertional desaturation in patients with chronic obstructive pulmonary disease. COPD. 2009; 6(6):478-87. DOI: 10.3109/15412550903341497. View

Kim C, Park Y, Park S, Park S, Kim C, Park S . COPD patients with exertional desaturation are at a higher risk of rapid decline in lung function. Yonsei Med J. 2014; 55(3):732-8. PMC: 3990067. DOI: 10.3349/ymj.2014.55.3.732. View

Culver B, Graham B, Coates A, Wanger J, Berry C, Clarke P . Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017; 196(11):1463-1472. DOI: 10.1164/rccm.201710-1981ST. View

Ulrich S, Hasler E, Saxer S, Furian M, Muller-Mottet S, Keusch S . Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial. Eur Heart J. 2017; 38(15):1159-1168. DOI: 10.1093/eurheartj/ehx099. View

Kim H, Kim K . How to Determine Right Ventricular Dysfunction in Pulmonary Hypertension. J Cardiovasc Imaging. 2021; 29(3):252-254. PMC: 8318816. DOI: 10.4250/jcvi.2021.0035. View

Lang R, Badano L, Mor-Avi V, Afilalo J, Armstrong A, Ernande L . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1):1-39.e14. DOI: 10.1016/j.echo.2014.10.003. View

10.

. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

11.

Morris N, Seale H, Harris J, Hall K, Lin A, Kermeen F . Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension. Respirology. 2016; 22(1):165-171. DOI: 10.1111/resp.12868. View

12.

Yeo J, Shin N, Ahn K, Seo M, Jang A, Kim M . Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension. Clin Hypertens. 2022; 28(1):10. PMC: 8973988. DOI: 10.1186/s40885-021-00191-1. View

13.

Park J, Na J, Lee J, Kim Y, Chang H . 2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary. Tuberc Respir Dis (Seoul). 2021; 85(1):1-10. PMC: 8743640. DOI: 10.4046/trd.2021.0022. View

14.

Ulrich S, Saxer S, Hasler E, Schwarz E, Schneider S, Furian M . Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial. Eur Respir J. 2019; 54(2). DOI: 10.1183/13993003.002762019. View

15.

Humbert M, Kovacs G, Hoeper M, Badagliacca R, Berger R, Brida M . 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022; 43(38):3618-3731. DOI: 10.1093/eurheartj/ehac237. View

16.

Oh J, Park J . Role of strain echocardiography in patients with hypertension. Clin Hypertens. 2022; 28(1):6. PMC: 8845306. DOI: 10.1186/s40885-021-00186-y. View

17.

Liu S, Chin C, Tseng C, Chen Y, Kuo H . Exertional Desaturation Has Higher Mortality Than Non-Desaturation in COPD. Medicina (Kaunas). 2021; 57(10). PMC: 8538486. DOI: 10.3390/medicina57101110. View